Insights into the Aggregation/Deposition and Structure of a Polydopamine FilmSurface-adherent polydopamine (PDA) films as multifunctional coatings can be easily deposited onto a wide range of materials through dopamine self-polymerization. However, a lack of in-depth understanding of PDA aggregation and deposition processes and definite structure elucidation of PDA make it challenging to tailor the surface characteristic and functionality of the PDA films. Herein, we demonstrate that the surface characteristics of the PDA films can be readily tuned by controlling the competitive interplay between PDA aggregation in solution and deposition on the substrate. Moreover, a structural investigation of the PDA films using analytical tools such as X-ray photoelectron spectroscopy (XPS), time-of-flight secondary ion mass spectrometry (ToF-SIMS), and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) allows us to propose a new structure model for the PDA building block. The (DHI)2/PCA trimer complex, which consists of two 5,6-dihydroxyindole (DHI) units and one pyrrolecarboxylic acid (PCA) moiety, is definitely identified as a primary building block of PDA, and its formation is steered by covalent interactions in the initial stages of polymerization. In latter stages, the (DHI)2/PCA trimer complexes are further linked primarily through noncovalent interactions to build up the supramolecular structure of PDA. This study provides new insights into the mechanisms of PDA buildup.
Stabilizing Cu<sup>+</sup> in Cu/SiO<sub>2</sub> Catalysts with a Shattuckite-Like Structure Boosts CO<sub>2</sub> Hydrogenation into MethanolJiafeng Yu, Meng Yang, Jixin Zhang et al.|ACS Catalysis|2020 Cu-based catalysts are widely employed for CO or CO2 hydrogenation into methanol. However, their catalytic performance highly depends on supports, and the real evolution of Cu species is still covered by active components. Herein, we supply a Cu/SiO2 catalyst prepared by flame spray pyrolysis (FSP), showing catalytic performance comparable to that of the active Cu/ZrO2 catalyst for methanol synthesis from CO2. It reaches 79% selectivity at a CO2 conversion of 5.2%, which is an outstanding selectivity among previously reported Cu/SiO2 catalysts, considering they are generally treated as nearly inert catalysts. In situ X-ray absorption spectroscopy (XAS) analysis shows that 5 times more Cu+ species in the FSP-Cu/SiO2 are stabilized in comparison to those in the traditional ammonia evaporation (AE) made catalyst even after reduction at 350 °C. A unique shattuckite-like precursor with a slightly distorted Cu–O–Si texture structure formed in the FSP-made catalyst is responsible for the enriched Cu+ species. Variations of intermediate formation and methanol production are found to have a good relationship with the amount of Cu+ species. According to the results of high-pressure in situ DRIFTS, we attribute this to the promotional effect of Cu+ on the stabilization of CO* intermediates, which inhibits CO desorption and facilitates further hydrogenation to CH3OH via the RWGS + CO-Hydro pathway. These results bring insights into the Cu reduction behavior and the function of Cu+ species during methanol production on Cu-based catalysts without the assistance of active supports.
Assembling UiO-66@TiO2 nanocomposites for efficient photocatalytic degradation of dimethyl sulfideZun Man, Meng Yang, Xiaochang Lin et al.|Chemical Engineering Journal|2021 β-Cyclodextrin polymer functionalized reduced-graphene oxide: Application for electrochemical determination imidaclopridMing Chen, Meng Yang, Wang Zhang et al.|Electrochimica Acta|2013 Micro/nano-structured TiO2 surface with dual-functional antibacterial effects for biomedical applicationsXiang Ge, Chengzu Ren, Yonghui Ding et al.|Bioactive Materials|2019 Implant-associated infections are generally difficult to cure owing to the bacterial antibiotic resistance which is attributed to the widespread usage of antibiotics. Given the global threat and increasing influence of antibiotic resistance, there is an urgent demand to explore novel antibacterial strategies other than using antibiotics. Recently, using a certain surface topography to provide a more persistent antibacterial solution attracts more and more attention. However, the clinical application of biomimetic nano-pillar array is not satisfactory, mainly because its antibacterial ability against Gram-positive strain is not good enough. Thus, the pillar array should be equipped with other antibacterial agents to fulfill the bacteriostatic and bactericidal requirements of clinical application. Here, we designed a novel model substrate which was a combination of periodic micro/nano-pillar array and TiO2 for basically understanding the topographical bacteriostatic effects of periodic micro/nano-pillar array and the photocatalytic bactericidal activity of TiO2. Such innovation may potentially exert the synergistic effects by integrating the persistent topographical antibacterial activity and the non-invasive X-ray induced photocatalytic antibacterial property of TiO2 to combat against antibiotic-resistant implant-associated infections. First, to separately verify the topographical antibacterial activity of TiO2 periodic micro/nano-pillar array, we systematically investigated its effects on bacterial adhesion, growth, proliferation, and viability in the dark without involving the photocatalysis of TiO2. The pillar array with sub-micron motif size can significantly inhibit the adhesion, growth, and proliferation of Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Such antibacterial ability is mainly attributed to a spatial confinement size-effect and limited contact area availability generated by the special topography of pillar array. Moreover, the pillar array is not lethal to S. aureus and E. coli in 24 h. Then, the X-ray induced photocatalytic antibacterial property of TiO2 periodic micro/nano-pillar array in vitro and in vivo will be systematically studied in a future work. This study could shed light on the direction of surface topography design for future medical implants to combat against antibiotic-resistant implant-associated infections without using antibiotics.